secwatch / observer
8-K filed March 5, 2024, 6:59 PM ET ticker RNAC CIK 0001453687
other material confidence high sentiment neutral materiality 0.55

Cartesian leases 20K sq ft cGMP facility in Frederick, MD; director resigns

Cartesian Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aymeric Sallin

Director
RNAC · Cartesian Therapeutics, Inc.
Effective
2024-02-28
Filed
March 5, 2024, 6:59 PM ET
On February 28, 2024, Aymeric Sallin, a member of the Board of Directors (the “Board”) of the Company, notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aymeric Sallin resigned as Director at Cartesian Therapeutics, Inc..

Action
resigned
Role
Director
Exact text from the filing
On February 28, 2024, Aymeric Sallin, a member of the Board of Directors (the “Board”) of the Company, notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Cartesian Therapeutics, Inc. entered into Lease Agreement with 7495 RP, LLC valued at Initial base rent of $902,353 per year for approximately 20,000 leasable square feet (effective 2024-02-28).

Action
entry
Agreement
lease
Counterparty
7495 RP, LLC
Value
Initial base rent of $902,353 per year for approximately 20,000 leasable square feet
Effective
2024-02-28
Exact text from the filing
On February 28, 2024, Cartesian Therapeutics, Inc. (the “Company”) entered into a lease agreement with 7495 RP, LLC (the “Landlord”), pursuant to which the Company agreed to lease from the Landlord the manufacturing space located at 7495 New Horizon Way, Frederick, Maryland 21702 (the “Lease Agreement”).
View on SEC.gov

737 material agreements filed in the last 30 days. Browse all material agreements →

Cartesian Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001140361-24-011282
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.